fda compounding semaglutide enforcement november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Warns on Certain Forms

Without benzyl alcohol, reconstituted peptide solution would need to be used within 24 hours (the standard for sterile water for injection)

They are not available over-the-counter due to the need for medical supervision and monitoring of potential side effects and effectiveness

Clinical data asks a harder question: what happens after months of treatment, structured follow-up, adverse-event tracking, and statistical comparison with placebo

All Simple Peptide products are labeled Research Use Only (RUO) and are intended strictly for laboratory, investigational, and scientific research purposes

It is an investigational drug and is only permitted in research settings.

The cold chain held through the shipping window